Experience
Elan Pharmaceuticals, Inc.
Eon Labs, Inc.
Represented Elan in Hatch-Waxman patent infringement actions involving Skelaxin®, including in two successful appeals before the Federal Circuit.
Elan Pharmaceuticals, Inc. v. Eon Labs, Inc., 1:04-cv-05540, E.D.N.Y., Judges Mauskopf, Trager, Mann
Elan Pharmaceuticals, Inc. v. Eon Labs, Inc., 09-1437, -1438, Fed. Cir., Judges Bryson, Gajarsa, Prost
Eon Labs, Inc. v. Elan Pharmaceuticals, Inc., 11-1070, Fed. Cir., Judges Newman, Rader, Reyna
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
AbbVie Inc.
Israel Bio-Engineering Project v. Amgen Inc., et al.
Amgen Inc., Immunex Corp.
Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
Innovative Therapies, Inc. v. Kinetic Concepts, Inc.
Kinetic Concepts, Inc.
Valeant Pharmaceuticals International, Inc. v. Mylan Pharmaceuticals Inc.
Valeant Pharmaceuticals International, Inc.
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Eagle Comtronics Inc. v. Arrow Communication Labs.
Eagle Comtronics Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.